Form 4 for TDOC Teladoc Health, Inc.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001477449-23-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-09-01 | TDOC | Turitz Andrew | EVP, Corp. DEVELOPMENT | M - OptEx | — | +1,347 | 25.1K | +6% | — |
| D | 2023-09-06 | 2023-09-05 | TDOC | Turitz Andrew | EVP, Corp. DEVELOPMENT | S - Sale+OE | $22.89 | -396 | 24.7K | -2% | -$9,064 |
| D | 2023-09-06 | 2023-09-01 | TDOC | Turitz Andrew | EVP, Corp. DEVELOPMENT | M - OptEx | $0.00 | -1,347 | 8,087 | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | M | A | 1,347 | — | 25,114 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-09-05 | S | D | 396 | $22.89 | 24,718 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 3 | Derivative | Restricted Stock Units | 2023-09-01 | M | D | 1,347 | $0.00 | 8,087 | D | — · — to — | 1,347 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |